Eli Lilly Issues Statement On Company Products Stolen In Connecticut

Eli Lilly is working with FDA’s Office of Criminal Investigations, and other law enforcement officials, to recover cases of select lots of pharmaceutical products that were stolen from one of Lilly's United States distribution centers located in Enfield, Connecticut, on Sunday, March 14, 2010, the company reported in a statement on its site.

A list of products stolen from the facility can be found at the bottom of this press release.
 
"Since early Sunday morning, Lilly has taken quick and appropriate actions to ensure the safety of our medicines,” said Dr. Fionnuala M. Walsh, Lilly's senior vice president of global quality, in the statement. "The U.S. pharmaceutical distribution system is tightly controlled and monitored, making it extremely difficult for stolen product to make it to patients through legitimate channels. However, we will continue to work closely with local and federal law enforcement authorities, the FDA, and our distribution partners to maintain the integrity of our drug supply chain."
 
Product from the affected lots that had been delivered from Lilly to retailers, wholesalers, or institutions prior to March 14 was approved for its intended use and is not affected by this event, the statement reported. Product containing these lot numbers has been distributed by Lilly within the United States, Puerto Rico, and its territories.
 
In its statement, Lilly is advising practitioners, retailers, and consumers to check all pharmaceutical products for signs of tampering or damage prior to purchase and/or use. Pharmacists and other health care professionals should not use the product if it has been removed from the sealed bottle or container, if the induction seal has been compromised, or in the case of glass vials, if the flip cap appears to have been disturbed in any way.
  
Lilly urges reporting of any information regarding the stolen products to FDA's Office of Criminal Investigations (OCI) by calling (800) 551-3989 or by visiting the OCI website www.fda.gov/OCI.
 
For medical or other related inquiries about this matter, contact Lilly at 1-800-LILLYRX (1-800-545-5979).
 
Impacted Products:
   
   
                              National Drug Code
    Product Description       (NDC)               Lot Number   Expiry Date
    -------------------       ------------------ ----------   -----------
    ALIMTA FINJ 500MG X1
     lyophilizedVIAL AM       00002-7623-01       A671076C      8/31/2011
    --------------------      -------------       --------      ---------
    CYMBALTA CAP 30MG X 30
     BTL AM                   00002-3240-30       A643056A      5/31/2012
    ----------------------    -------------       --------      ---------
    CYMBALTA CAP 30MG X 30
     BTL AM                   00002-3240-30       A662278C      7/31/2012
    ----------------------    -------------       --------      ---------
    CYMBALTA CAP 30MG X 30
     BTL AM                   00002-3240-30       A662281A      7/31/2012
    ----------------------    -------------       --------      ---------
    CYMBALTA CAP 60MG X30BOTL
     AM                       00002-3270-30       A672999A      9/30/2011
    ------------------------- -------------       --------      ---------
    CYMBALTA CAP 60MG
     X1000BOTL AM             00002-3270-04       A685790A     10/31/2011
    -----------------         -------------       --------     ----------
    EFFIENT TAB 10MG X30BOTL
     AM                       00002-4759-30       A650259A     12/31/2010
    ------------------------ -------------       --------     ----------
    GEMZAR 200MG VIALS        00002-7501-01       A670185A      8/31/2011
    ------------------        -------------       --------      ---------
    GEMZAR 1 GRAM VIALS       00002-7502-01       A668160D      8/31/2011
    -------------------       -------------       --------      ---------
    GEMZAR 1 GRAM VIALS       00002-7502-01       A670177A      9/30/2011
    -------------------       -------------       --------      ---------
    GEMZAR 1 GRAM VIALS       00002-7502-01       A670180A      8/31/2011
    -------------------       -------------       --------      ---------
    GEMZAR 1 GRAM VIALS       00002-7502-01       A670182A      9/30/2011
    -------------------       -------------       --------      ---------
    PROZAC PULV 20MG X 30
     BOTL DP                  00777-3105-30       A599046D      1/31/2012
    ---------------------     -------------       --------      ---------
    PROZAC PULV 20MG X 30
     BOTL DP                  00777-3105-30       A689619D     10/31/2012
    ---------------------     -------------       --------     ----------
    PROZAC PULV 40MG X 30
     BOTL DP                  00777-3107-30       A602567A      1/31/2012
    ---------------------     -------------       --------      ---------
    STRATTERA CAP 10MG X 30
     BOTL AM                  00002-3227-30       A621189A      3/31/2012
    -----------------------   -------------       --------      ---------
    STRATTERA CAP 25MG X 30
     BOTL AM                  00002-3228-30       A678353A      2/29/2012
    -----------------------   -------------       --------     ---------
    STRATTERA CAP 60MG X 30
     BOTL AM                  00002-3239-30       A621202A      3/31/2012
    -----------------------   -------------       --------      ---------
    STRATTERA CAP 100MG
     X30BOTL AM               00002-3251-30       A621205C      3/31/2012
    -------------------       -------------       --------      ---------
    SYMBYAX CAP 6/25MG X 30
     BOTL AM                  00002-3231-30       A562684A     10/31/2011
    -----------------------   -------------       --------     ----------
    ZYPREXA TAB 2.5MG X30BOTL
     AM                       00002-4112-30       A644710A      5/31/2011
    ------------------------- -------------       --------      ---------
    ZYPREXA TAB 5MG X30BOTL
     AM                       00002-4115-30       A668322A      8/31/2011
    -----------------------   -------------       --------      ---------
    ZYPREXA TAB 7.5MG X30BOTL
     AM                       00002-4116-30       A646193A      5/31/2011
    ------------------------- -------------       --------      ---------
    ZYPREXA TAB 10MG X30BOTL
     AM                       00002-4117-30       A641350C      5/31/2012
    ------------------------ -------------       --------      ---------
    ZYPREXA TAB 10MG X30BOTL
     AM                       00002-4117-30       A668323A      8/31/2012
    ------------------------ -------------       --------      ---------
    ZYPREXA TAB 15MG X 1000
     BOTL AM                  00002-4415-04       A647860A      5/31/2012
    -----------------------   -------------       --------      ---------
    ZYPREXA TAB 15MG X30BOTL
     AM                       00002-4415-30       A690238A     10/31/2012
    ------------------------ -------------       --------     ----------
    ZYPREXA TAB 20MG X30BOTL
     AM                       00002-4420-30       A677956A      8/31/2012
    ------------------------ -------------       --------      ---------
    ZYPREXA TAB 20MG X30BOTL
     AM                       00002-4420-30       A677958C      8/31/2012
    ------------------------ -------------       --------      ---------
    ZYPREXA TAB ID100 10MG
     XID100BLCD AM            00002-4117-33       A632252D      4/30/2012
    ----------------------    -------------       --------      ---------
    ZYPREXA ZYDIS TAB 5MG X
     30 SACH AM               00002-4453-85       976041A        7/1/2012
    -----------------------   -------------       -------        --------
    ZYPREXA ZYDIS TAB 10MG X
     30 SACH AM               00002-4454-85       971159A        7/1/2012
    ------------------------ -------------       -------        --------
    ZYPREXA ZYDIS TAB 20MG X
     30 SACH AM               00002-4456-85       963999A        5/1/2012
    ------------------------ -------------       -------        --------
 
Your rating: None Average: 4.5 (2 votes)